Maravai LifeSciences Ownership | Who Owns Maravai LifeSciences?


OverviewForecastRevenueFinancialsChartTranscripts

Maravai LifeSciences Ownership Summary


Maravai LifeSciences is owned by 83.29% institutional investors, 11.72% insiders, and 4.99% retail investors. Gtcr is the largest institutional shareholder, holding 13.89% of MRVI shares. Canada Life US Small-Mid Cap Growth A is the top mutual fund, with 3.22% of its assets in Maravai LifeSciences shares.

MRVI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMaravai LifeSciences83.29%11.72%4.99%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Gtcr20.15M13.89%$57.02M
Blackrock9.73M7.35%$69.66M
Braidwell lp10.24M7.06%$28.98M
Blackrock funding, inc. /de9.35M6.44%$26.45M
12 west capital management lp7.26M5.00%$20.55M
Vanguard group7.17M4.95%$23.29M
Mackenzie financial6.31M4.35%$17.85M
Renaissance4.26M2.94%$12.07M
Tejara capital3.50M2.41%$9.89M
Monaco asset management sam3.42M2.36%$9.68M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Brummer multi-strategy ab759.74K8.95%$2.15M
12 west capital management lp7.26M3.47%$20.55M
Tejara capital3.50M3.26%$9.89M
Monaco asset management sam3.42M1.79%$9.68M
Gtcr20.15M1.51%$57.02M
Braidwell lp10.24M0.97%$28.98M
Yost capital management, lp126.06K0.59%$409.68K
Point72 (difc)2.59M0.49%$7.43M
Philosophy capital management2.64M0.46%$7.46M
General american investors1.72M0.32%$4.86M

Top Buyers

HolderShares% AssetsChange
Blackrock9.73M0.00%3.31M
Braidwell lp10.24M0.97%1.89M
Citadel advisors1.48M0.00%866.87K
Vanguard fiduciary trust774.58K0.00%774.58K
Two sigma investments, lp1.58M0.00%734.43K

Top Sellers

HolderShares% AssetsChange
T. rowe price investment management1.00M0.00%-5.34M
Alyeska investment group---5.33M
Jennison associates---2.99M
First trust advisors lp---2.40M
Wellington management group llp---2.36M

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust774.58K0.00%774.58K$2.19M
Tudor investment corp et al396.92K0.00%396.92K$1.12M
Capricorn fund managers339.73K0.15%339.73K$961.43K
Gsa capital partners llp168.55K0.03%168.55K$477.00K
Yost capital management, lp126.06K0.59%126.06K$409.68K

Sold Out

HolderChange
Sjs investment consulting-2.00
Jfs wealth advisors-5.00
True wealth design-9.00
Srs capital advisors-15.00
Steward partners investment advisory-20.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026162-2.41%120,838,524-6.62%831.04%778.45%52-11.86%
Dec 31, 202542-74.23%14,692,563-88.76%100.12%20-73.68%15-66.67%
Sep 30, 202552-65.79%18,956,142-85.37%130.16%21-73.08%16-60.98%
Jun 30, 2025151-21.35%129,251,4490.45%891.11%77-26.67%41-21.15%
Mar 31, 20251901.60%128,243,066-8.54%890.91%10311.96%52-16.13%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Canada Life US Small-Mid Cap Growth A4.57M3.22%-
Canada Life US Small-Mid Cap Growth F4.57M3.10%-
Vanguard US Total Market Shares ETF3.94M2.74%547.00K
Vanguard Total Stock Mkt Idx Inv3.92M2.66%-
iShares Russell 2000 ETF2.56M1.74%21.57K
First Eagle Small Cap Opportunity I2.39M1.62%213.93K
First Eagle US Small Cap Strategy2.20M1.49%616.55K
T. Rowe Price US Small-Cap Core Equity2.16M1.49%208.96K
Glenmede Small Cap Equity2.03M1.43%-14.85K
Glenmede Small Cap Equity Adv2.03M1.43%-14.85K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 09, 2026ORESHACK KURT General CounselSell$126.50K
Jun 10, 2026ORESHACK KURT General CounselSell$127.50K
Dec 08, 2025LUCIER GREGORY T-Buy$178.10K
Dec 05, 2025LUCIER GREGORY T-Buy$190.45K
Nov 13, 2025Brust Bernd Chief Executive OfficerBuy$702.69K

Insider Transactions Trends


DateBuySell
2026 Q2-2
2026 Q1--
2025 Q45-
2025 Q3--
2025 Q2--

MRVI Ownership FAQ


Who Owns Maravai LifeSciences?

Maravai LifeSciences shareholders are primarily institutional investors at 83.29%, followed by 11.72% insiders and 4.99% retail investors. The average institutional ownership in Maravai LifeSciences's industry, Biotech Stocks , is 35.75%, which Maravai LifeSciences exceeds.

Who owns the most shares of Maravai LifeSciences?

Maravai LifeSciences’s largest shareholders are Gtcr (20.15M shares, 13.89%), Blackrock (9.73M shares, 7.35%), and Braidwell lp (10.24M shares, 7.06%). Together, they hold 28.30% of Maravai LifeSciences’s total shares outstanding.

Does Blackrock own Maravai LifeSciences?

Yes, BlackRock owns 7.35% of Maravai LifeSciences, totaling 9.73M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 69.66M$. In the last quarter, BlackRock increased its holdings by 3.31M shares, a 51.67% change.

Who is Maravai LifeSciences’s biggest shareholder by percentage of total assets invested?

Brummer multi-strategy ab is Maravai LifeSciences’s biggest shareholder by percentage of total assets invested, with 8.95% of its assets in 759.74K Maravai LifeSciences shares, valued at 2.15M$.

Who is the top mutual fund holder of Maravai LifeSciences shares?

Canada Life US Small-Mid Cap Growth A is the top mutual fund holder of Maravai LifeSciences shares, with 3.22% of its total shares outstanding invested in 4.57M Maravai LifeSciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools